TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/18/23 16:30 | 10/16/23 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Koppel Adam | MA | DT | P | 125,000 | 22.81 | 0 | 5,480 | 9 | 65,683 | I | |||||||||||||||
11/12/20 17:54 | 11/9/20 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Koppel Adam | MA | DT | P | 3,423 | 10.30 | 0 | 332 | 1 | 60,632 | I | |||||||||||||||
10/29/20 20:00 | 10/27/20 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Koppel Adam | MA | DT | P | 100,000 | 10.00 | 0 | 10,000 | 20 | 60,300 | I | |||||||||||||||
1/16/20 16:20 | 1/14/20 | APTX | Aptinyx Inc. | DE | Health | Drug | Pharmaceutical Preparations | Koppel Adam | MA | DT | P | 10,000 | 3.00 | 0 | 3,333 | 150 | 5,558 | I | |||||||||||||||
6/26/18 16:50 | 6/25/18 | APTX | Aptinyx Inc. | DE | Health | Drug | Pharmaceutical Preparations | Koppel Adam | MA | D | P.d | 6,400 | 16.00 | 0 | 400 | 22 | 2,225 | I | |||||||||||||||
2/1/18 19:07 | 1/30/18 | SLDB | Solid Biosciences Inc. | Health | BioPrd | Biological Products, (No Diag | Koppel Adam | MA | D | P.d | 4,800 | 16.00 | 0 | 300 | 18 | 1,989 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |